Thus, we propose that the expression of TLR3 and secretion of pro-/anti-inflammatory cytokines would correlate with the efficacy of polyI:C (and possibly, Hiltonol) treatment of lung cancer cells. This evidence concerns the gene TLR3 and lung carcinoma.